Monday, September 3, 2012
We have entered an age of
austerity that, given the fecklessness of the political classes, won't end any
time soon. Against that backdrop, the global science community must decide how
to succeed with less money.
Major changes in the way
science is funded and conducted are needed to ensure the most pressing
scientific problems are addressed by the best scientists. The patients who rely
on the biomedical innovation ecosystem deserve nothing less, and the taxpayers
who foot the bill should be demanding it.